Delayed Prostate Cancer Therapy Binghamton NY

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues.

Local Companies

Arun V Sheth
(607) 798-5307
169 Riverside Dr
Binghamton, NY
Kent B LaMoureux
(607) 798-5230
169 Riverside Dr
Binghamton, NY
DANIEL BELLINA, MD
(607) 763-6850
30 Harrison Street
Johnson City, NY
Joseph Andrew Readling, MD
607-763-6850
30 Harrison St Ste 100
Johnson City, NY
Jonathan David Klos, MR
607-798-5818
169 Riverside Dr
Binghamton, NY
Ronald P Harris
(607) 763-6850
30 Harrison St
Johnson City, NY
Jonathan D Kloss
(607) 798-5307
169 Riverside Dr
Binghamton, NY
MADHURI YALAMANCHILI, MD
(607) 798-5307
169 Riverside Drive
Binghamton, NY
Madhuri Yalamanchili, MD
607-748-3237
169 Riverside Dr
Binghamton, NY
Adam Scott Levy, MD
607-772-1355
15 Bennett Ave
Binghamton, NY
Data Provided by:
    

Provided By:

MONDAY, July 27 (HealthDay News) -- Men who delay treatment for their early prostate cancer are not especially anxious about living with the disease, new Dutch research shows.

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues. The findings are published in the Sept. 1 issue of Cancer.

The researchers surveyed 129 men regarding their levels of depression and anxiety over their treatment decision. More than 80 percent scored favorably low and compared well emotionally with patients who had opted for more aggressive treatment, the study found.

Men who were in poor general health and those with neurotic personalities expressed higher levels of anxiety and distress, suggesting that factors other than cancer may impact a patient's emotional response, the researchers noted.

The study is especially useful in an era when prostate-specific antigen tests and other screening exams are uncovering prostate cancer at increasingly earlier stages. Many physicians practice a "wait-and-see" approach to treatment, saving the more aggressive therapies for when the cancer grows or spreads, according to information in a news release from the American Cancer Society.

Nationally, prostate cancer is one of the most common cancers and is expected to strike more than 190,000 men this year, and result in over 27,000 deaths, according to the American Cancer Society. But thanks to more effective screenings and treatments, while one in six U.S. men will develop prostate cancer during their lifetime, only one in 35 will actually die of the disease. What's more, there are more than 2 million men in the United States who have been diagnosed with prostate cancer at some point and are still alive today, according to the society.

More information

The U.S. National Cancer Institute has more on prostate cancer.

SOURCE: American Cancer Society, news release, July 27, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Hormone Therapy for Breast Cancer Binghamton NY
Breast tenderness in women taking estrogen/progestin hormone replacement therapy could signal increased chances of developing breast cancer, a new study says. Women taking estrogen plus progestin who reported developing breast tenderness after starting the hormone therapy were 48 percent more likely to develop invasive breast cancer than women on hormone therapy who did not experience breast tenderness.
- Head and Neck Cancer Treatment Binghamton NY
- Drug Combo Proves Powerful Against Lung Cancer Binghamton NY
- Hormone Therapy for Prostate Cancer Binghamton NY
- Hormone Therapy for Early Prostate Cancer Binghamton NY
- Diagnosis of Prostate Cancer Binghamton NY
- Hormone Therapy for Lung Cancer Binghamton NY
- Attack Of The Cancer Fighting Tomatoes Binghamton NY
- Exercise for Prostate Cancer Binghamton NY
- Open Prostatectomy Versus Laparoscopic Procedure Binghamton NY